Literature DB >> 9187364

Cloning and functional expression of the murine homologue of proteinase 3: implications for the design of murine models of vasculitis.

D E Jenne1, L Fröhlich, A M Hummel, U Specks.   

Abstract

Anti-neutrophil cytoplasmic autoantibodies recognizing conformational epitopes (c-ANCA) of proteinase 3 (PR3) from azurophil granules are a diagnostic hallmark in Wegener's granulomatosis (WG). Because a functional PR3 homologue has not been identified in rodents, it is difficult to assess immunopathological responses in rats or mice immunized with patients' derived c-ANCA or human PR3. Here we report the full length cDNA cloning and functional expression of murine PR3 in HMC-1 cells. Recombinant murine PR3 shows highly similar substrate specificities towards synthetic peptides and is inhibited by human alpha1-proteinase inhibitor like human PR3. However, neither human c-ANCA, rabbit sera nor mouse monoclonal antibodies to human PR3 recognize the murine homologue. Consequently, it is unlikely that disease observed in mice after immunization with c-ANCA or human PR3 is caused by pathogenic antibodies directed against mouse PR3. Recombinant human-mouse chimaeric variants will be a valuable new tool to localize the disease-specific immunodominant epitopes in human PR3.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187364     DOI: 10.1016/s0014-5793(97)00418-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Small vessel vasculitis of the lung.

Authors:  M I Schwarz; K K Brown
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

2.  Comparative aspects of murine proteinase 3.

Authors:  Manfred Relle; Thomas Thomaidis; Peter R Galle; Andreas Schwarting
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

3.  Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegener's autoantigen.

Authors:  Francisco Silva; Amber M Hummel; Dieter E Jenne; Ulrich Specks
Journal:  J Autoimmun       Date:  2010-12       Impact factor: 7.094

4.  PR3 antibodies do not induce renal pathology in a novel PR3-humanized mouse model for Wegener's granulomatosis.

Authors:  Manfred Relle; Hannes Cash; Nadine Schommers; Kurt Reifenberg; Peter R Galle; Andreas Schwarting
Journal:  Rheumatol Int       Date:  2012-04-06       Impact factor: 2.631

5.  Anti-PR3 immune responses induce segmental and necrotizing glomerulonephritis.

Authors:  V C Primo; S Marusic; C C Franklin; W H Goldmann; C G Achaval; R N Smith; M A Arnaout; B Nikolic
Journal:  Clin Exp Immunol       Date:  2009-12-14       Impact factor: 4.330

6.  Epitope mapping of anti-PR3 antibodies using chimeric human/mouse PR3 recombinant proteins.

Authors:  D Selga; M Segelmark; J Wieslander; L Gunnarsson; T Hellmark
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

7.  Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis.

Authors:  J D Finkielman; P A Merkel; D Schroeder; G S Hoffman; R Spiera; E W St Clair; J C Davis; W J McCune; A Lears; S R Ytterberg; A M Hummel; M A Viss; T Peikert; J H Stone; U Specks
Journal:  Clin Exp Rheumatol       Date:  2009 Jan-Feb       Impact factor: 4.473

Review 8.  Optimizing the translational value of animal models of glomerulonephritis: insights from recent murine prototypes.

Authors:  Mary H Foster
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-22

9.  Rats and mice immunised with chimeric human/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes.

Authors:  Ymke M van der Geld; Thomas Hellmark; Daina Selga; Peter Heeringa; Minke G Huitema; Pieter C Limburg; Cees G M Kallenberg
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

10.  Transfer of PBMC From SSc Patients Induces Autoantibodies and Systemic Inflammation in Rag2-/-/IL2rg-/- Mice.

Authors:  Xiaoyang Yue; Frank Petersen; Yaqing Shu; Brigitte Kasper; Junie D Tchudjin Magatsin; Marjan Ahmadi; Junping Yin; Jacqueline Wax; Xiaoqing Wang; Harald Heidecke; Peter Lamprecht; Antje Müller; Xinhua Yu; Gabriela Riemekasten
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.